These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24189189)

  • 21. Neurodegenerative memory disorders: a potential role of environmental toxins.
    Caban-Holt A; Mattingly M; Cooper G; Schmitt FA
    Neurol Clin; 2005 May; 23(2):485-521. PubMed ID: 15757794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum and Alzheimer's Disease.
    Colomina MT; Peris-Sampedro F
    Adv Neurobiol; 2017; 18():183-197. PubMed ID: 28889268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated levels of ferrimagnetic metals in foodchains supporting the Guam cluster of neurodegeneration: do metal nucleated crystal contaminants [corrected] evoke magnetic fields that initiate the progressive pathogenesis of neurodegeneration?
    Purdey M
    Med Hypotheses; 2004; 63(5):793-809. PubMed ID: 15488650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pacific paradigms of environmentally-induced neurological disorders: clinical, epidemiological and molecular perspectives.
    Garruto RM
    Neurotoxicology; 1991; 12(3):347-77. PubMed ID: 1745428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Linking pathways in the developing and aging brain with neurodegeneration.
    Kovacs GG; Adle-Biassette H; Milenkovic I; Cipriani S; van Scheppingen J; Aronica E
    Neuroscience; 2014 Jun; 269():152-72. PubMed ID: 24699227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Concentrations of fluorine, aluminum and magnesium in some structures of the central nervous system of rats exposed to aluminum and fluorine in drinking water].
    Lubkowska A; Chlubek D; Machoy-Mokrzyńska A; Noceń I; Zyluk B; Nowacki P
    Ann Acad Med Stetin; 2004; 50 Suppl 1():73-6. PubMed ID: 16892590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment.
    Frisardi V; Solfrizzi V; Capurso C; Kehoe PG; Imbimbo BP; Santamato A; Dellegrazie F; Seripa D; Pilotto A; Capurso A; Panza F
    J Alzheimers Dis; 2010; 20(1):17-30. PubMed ID: 20378957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aluminum, restraint stress and aging: behavioral effects in rats after 1 and 2 years of aluminum exposure.
    Roig JL; Fuentes S; Teresa Colomina M; Vicens P; Domingo JL
    Toxicology; 2006 Feb; 218(2-3):112-24. PubMed ID: 16289752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifaceted effects of aluminium in neurodegenerative diseases: A review.
    Maya S; Prakash T; Madhu KD; Goli D
    Biomed Pharmacother; 2016 Oct; 83():746-754. PubMed ID: 27479193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aluminum as a toxicant.
    Becaria A; Campbell A; Bondy SC
    Toxicol Ind Health; 2002 Aug; 18(7):309-20. PubMed ID: 15068131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences.
    Gilbert ME; Rovet J; Chen Z; Koibuchi N
    Neurotoxicology; 2012 Aug; 33(4):842-52. PubMed ID: 22138353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental aluminum encephalomyelopathy. Relationship to human neurodegenerative disease.
    Rao JK; Katsetos CD; Herman MM; Savory J
    Clin Lab Med; 1998 Dec; 18(4):687-98, viii. PubMed ID: 9891607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxic effects of aluminium exposure as a potential risk factor for Alzheimer's disease.
    Dey M; Singh RK
    Pharmacol Rep; 2022 Jun; 74(3):439-450. PubMed ID: 35088386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum forms in drinking water and risk of Alzheimer's disease.
    Gauthier E; Fortier I; Courchesne F; Pepin P; Mortimer J; Gauvreau D
    Environ Res; 2000 Nov; 84(3):234-46. PubMed ID: 11097797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retardation of brain aging by chronic treatment with melatonin.
    Bondy SC; Lahiri DK; Perreau VM; Sharman KZ; Campbell A; Zhou J; Sharman EH
    Ann N Y Acad Sci; 2004 Dec; 1035():197-215. PubMed ID: 15681809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging.
    Savory J; Rao JK; Huang Y; Letada PR; Herman MM
    Neurotoxicology; 1999 Oct; 20(5):805-17. PubMed ID: 10591516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation, neurodegenerative diseases, and environmental exposures.
    Campbell A
    Ann N Y Acad Sci; 2004 Dec; 1035():117-32. PubMed ID: 15681804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases.
    Monnet-Tschudi F; Zurich MG; Boschat C; Corbaz A; Honegger P
    Rev Environ Health; 2006; 21(2):105-17. PubMed ID: 16898674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Occupational exposure to aluminum and its biomonitoring in perspective.
    Riihimäki V; Aitio A
    Crit Rev Toxicol; 2012 Nov; 42(10):827-53. PubMed ID: 23013241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.